휴마사이트(HUMA)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $0.58 (+0.59%), 시가총액 $0.20B, 52주 최저~최고 $0.57 ~ $2.77.
Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial
휴마사이트의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
휴마사이트의 현재 주가는 $0.58 (+0.59%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
휴마사이트의 시가총액은 약 $0.20B입니다.
Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions a